Examples of GSK Shares in a sentence
GSK Shares or GSK ADSs notionally allocated in this way do not entitle Non-Executive Directors to receive dividends paid by GSK, but equivalent amounts are re-invested on an annual basis so as to increase their notional allocations of GSK Shares or GSK ADSs. It follows that Haleon Shares issued as part of the Demerger will not be issued in respect of GSK Shares or GSK ADSs notionally allocated under the GSK NED Share Plan.
Relief from the restrictions in Section 3230 and 3240 may be granted by Special Permit from the Zoning Board of Appeals, or in case where a Site Plan review is required, the Planning Board shall be the Special Permit Granting Authority.
Shareholders will continue to own their GSK Shares unless they sell or transfer them in the usual course.
The intention of the GSK Share Consolidation is to: • reduce the number of GSK Shares which will increase the price of a GSK Share so that there will be general comparability between GSK’s share price before and after the Separation (subject to any interim market movements).
Instead, the Haleon Shares issued to each such Shareholder pursuant to the Demerger should be treated as the same asset, and as having been acquired at the same time, asthe GSK Shares already held by them.
The ratio for the GSK Share Consolidation cannot be fixed at this time as it is dependent on fluctuations in the volume and price of trading of GSK Shares in the period between open of trading at 8 a.m. and close of trading at 4.30 p.m. on Monday 18 July 2022 (the “VWAP Period”).
The New GSK Shares will be registered with ISIN number GB00BN7SWP63 and SEDOL number BN7SWP6 with effect from 8 a.m. on Tuesday 19 July 2022.
If the proceeds exceed the base cost of the Shareholder’s New Holding, or if a Shareholder does not hold enough Existing GSK Shares such that they are not entitled to receive a New GSK Share, or if the amount is not considered “small” by HMRC, the Shareholder will be treated as disposing of part of their GSK Shares and may, depending on circumstances, be subject to tax in respect of any chargeable gain thereby realised.
Investments are made under the terms of the GSK NED Share Plan which makes notional allocations of GSK Shares or GSK ADSs to Non-Executive Directors equal to the reinvested fees.
Accordingly, the GSK Board unanimously recommends that Shareholders vote in favour of the Resolutions to be proposed at the General Meeting, as each Director has undertaken to do in respect of his or her own beneficial shareholding (where a Director holds GSK Shares and/or GSK ADSs), amounting in aggregate to 3,352,127 GSK Shares, representing approximately 0.07 per cent.